You are here: Industry Insights > Losartan

News List

Losartan drug recall expanded to include five more lots europeanpharmaceuticalreview
September 26, 2019
FDA announces the voluntary recall for the losartan medications has been extended to include more lots, after impurities were found in the drugs.
Sandoz Recalls Losartan Potassium, Ezetimibe Prescription Bottles americanpharmaceuticalreview
September 03, 2019
Sandoz has voluntarily recalled losartan potassium and ezetimibe in prescription drug bottles in the U.S. due to failure to meet child-resistant closure requirements.
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc. drugs
June 12, 2019
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc.
Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Impurity drugs
May 20, 2019
Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Impurity.
FDA finds testing issues at Torrent plant fiercepharma
May 14, 2019
Torrent had to recall 2.2 million bottles of losartan blood pressure drugs that were made with an API from Hetero Labs that was discovered to be tainted with impurities that are considered cancer causing. (Torrent Pharmaceuticals)
NEWS FDA finds another carcinogenic impurity in ARB blood pressure drug europeanpharmaceuticalreview
April 10, 2019
FDA is ‘deeply concerned’ about a third type of nitrosamine impurity detected in angiotensin II receptor blocker (ARB) medicines…
Three further Losartan batches recalled europeanpharmaceuticalreview
March 27, 2019
The MHRA has recalled three batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid…
Torrent Expands its Voluntary Recall of Losartan americanpharmaceuticalreview
January 24, 2019
Torrent Pharmaceuticals is further expanding its voluntary recall to include six additional lots of losartan potassium and hydrochlorothiazide combination tablets, for a total of 16 lots of losartan-containing medicines....
Losartan could improve ovarian cancer treatment europeanpharmaceuticalreview
January 17, 2019
Researchers have found that losartan could be beneficial for those undergoing cancer treatment as it may enhance its effectiveness…
Sandoz Issues Recall of Losartan Potassium, Hydrochlorothiazide americanpharmaceuticalreview
November 12, 2018
Sandoz Issues Recall of Losartan Potassium, Hydrochlorothiazide